TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33983765

Group type: EXPERIMENTAL
Intervention: 300 mg/day pregabalin (EXP 1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 450 mg/day pregabalin (EXP 2)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 32449528

Group type: EXPERIMENTAL
Intervention: COVID-19 group
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 141
Study: 33860850

Group type: EXPERIMENTAL
Intervention: Probiotics (2 g for 30 days)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (2 g whey powder for 30 days)
Number of subjects: 6
Study: 32672864

Group type: EXPERIMENTAL
Intervention: Nuevo Amanecer (NA‐II) stress management program
Number of subjects: 153
Study: 34008159

Group type: EXPERIMENTAL
Intervention: HRV-Biofeedback (HRV-BF)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 46
Study: 34214639

Group type: EXPERIMENTAL
Intervention: Pre‐schoolers’ Food Courage 2.0 intervention
Number of subjects: 10
Study: 33186683

Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT)
Number of subjects: 22
Study: 33678132

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered compensatory memory skills programme (6 weeks via internet videoconferencing)
Number of subjects: 5
Study: 33797347

Group type: EXPERIMENTAL
Intervention: Healer-led training for PPE education and training, general HIV prevention education, and three educational outreach visits.
Number of subjects: 122

Group type: COMPARATOR
Intervention: Clinician-led training for PPE education and training, general HIV prevention education, and three educational outreach visits.
Number of subjects: 122
Study: 32428059

Group type: EXPERIMENTAL
Intervention: LED
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LED/HP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LED/CP
Number of subjects: 100

Group type: COMPARATOR
Intervention: HP
Number of subjects: 100

Group type: COMPARATOR
Intervention: CP
Number of subjects: 100
Study: 34372971

Group type: EXPERIMENTAL
Intervention: C/P + T (carboplatin/paclitaxel + trastuzumab)
Number of subjects: 60

Group type: COMPARATOR
Intervention: C/P (carboplatin/paclitaxel)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trastuzumab maintenance therapy
Number of subjects: 60
Study: 32005476

Group type: EXPERIMENTAL
Intervention: Humorous video (H)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Unhumorous video (U)
Number of subjects: 38
Study: 35562555

Group type: EXPERIMENTAL
Intervention: CPAP plus standard cardiovascular care
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard care alone (UC group)
Number of subjects: 102
Study: 33979843

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic treatment
Number of subjects: 7
Study: 32303413

Group type: EXPERIMENTAL
Intervention: High-efficiency hemodialysis (HED)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hemodiafiltration (HDF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-efficiency hemodialysis (HED) and Hemodiafiltration (HDF)
Number of subjects: 10
Study: 34392336

Group type: EXPERIMENTAL
Intervention: Algorithm derivation group (n=457)
Number of subjects: 918

Group type: EXPERIMENTAL
Intervention: Algorithm validation group (n=461)
Number of subjects: 918

Group type: EXPERIMENTAL
Intervention: Without baseline risk-stratifier
Number of subjects: 918
Study: 34159386

Group type: EXPERIMENTAL
Intervention: Difficulty waking up for school among JHS boys
Number of subjects: 100050

Group type: EXPERIMENTAL
Intervention: Difficulty waking up for school among JHS girls
Number of subjects: 100050

Group type: EXPERIMENTAL
Intervention: Difficulty waking up for school among SHS boys
Number of subjects: 100050

Group type: EXPERIMENTAL
Intervention: Difficulty waking up for school among SHS girls
Number of subjects: 100050

Group type: EXPERIMENTAL
Intervention: Risk factors for school tardiness
Number of subjects: 100050

Group type: EXPERIMENTAL
Intervention: Risk factors for school absence
Number of subjects: 100050

Group type: EXPERIMENTAL
Intervention: Monthly smoking days for JHS girls
Number of subjects: 100050
Study: 35457447

Group type: COMPARATOR
Intervention: Anodal tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methylphenidate (MPH)
Number of subjects: 0
Study: 34133657

Group type: COMPARATOR
Intervention: Home-based training
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Center-based training
Number of subjects: 23
Study: 35069955

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg (S group)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 88
Study: 32852294

Group type: EXPERIMENTAL
Intervention: 3% chloroprocaine (CP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 2% lidocaine with 150 µg epinephrine, 2 mL of 8.4% bicarbonate, and 100 µg fentanyl (LEBF)
Number of subjects: 70
Study: 33682592

Group type: EXPERIMENTAL
Intervention: Heartfulness meditation
Number of subjects: 155

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 155
Study: 32472742

Group type: EXPERIMENTAL
Intervention: NEPA (single oral dose)
Number of subjects: 667

Group type: COMPARATOR
Intervention: APR/GRAN (3-day regimen)
Number of subjects: 667
Study: 34452673

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention plus behavioral activation (BMI + BA)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Brief motivational intervention plus supportive counseling (BMI + SC)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: BMI + BA
Number of subjects: 113
Study: 616681197

Group type: EXPERIMENTAL
Intervention: Olopatadine HCl 0.77%
Number of subjects: 448

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 448

Group type: COMPARATOR
Intervention: Olopatadine 0.2%
Number of subjects: 448
Study: 35536391

Group type: EXPERIMENTAL
Intervention: Patient-assisted compression (PAC)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Standard compression (SC)
Number of subjects: 444
Study: 33857782

Group type: EXPERIMENTAL
Intervention: Decontamination process (time, dry heat, or ultraviolet C light [UVC])
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Heat treatment
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: UVC treatment
Number of subjects: 15
Study: 34809479

Group type: EXPERIMENTAL
Intervention: Dasiglucagon autoinjector
Number of subjects: 54
Study: 33863564

Group type: EXPERIMENTAL
Intervention: 100μg selenium tablet twice a day for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo tablets (100μg of starch) twice a day for 6 months
Number of subjects: 30
Study: 34360460

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation for one week
Number of subjects: 19

Group type: COMPARATOR
Intervention: Usual diet (Control)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 19
Study: 32213226

Group type: COMPARATOR
Intervention: Normal Glucose Tolerance (NGT)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Prediabetes
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Type 2 Diabetes Mellitus (T2DM)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency
Number of subjects: 1500
Study: 35743485

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) treatment with a diode laser (810 nm, 6 J/cm2) for 6 weeks (1 session per week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo control (simulated treatment)
Number of subjects: 60
Study: 33564816

Group type: EXPERIMENTAL
Intervention: Higher relative protein intake
Number of subjects: 65164

Group type: EXPERIMENTAL
Intervention: Increased relative fat intake
Number of subjects: 65164
Study: 33054724

Group type: EXPERIMENTAL
Intervention: Precision early ambulation (PEA)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Routine ambulation (Control)
Number of subjects: 178
Study: 34736908

Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 213

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 213

Group type: COMPARATOR
Intervention: Oxycodone
Number of subjects: 213
Study: 33053561

Group type: EXPERIMENTAL
Intervention: Subthreshold EPM PRP
Number of subjects: 28

Group type: COMPARATOR
Intervention: Threshold PASCAL PRP
Number of subjects: 28
Study: 32915975

Group type: EXPERIMENTAL
Intervention: R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone)
Number of subjects: 729
Study: 34172554

Group type: EXPERIMENTAL
Intervention: Mindfetalness (self-assessment method)
Number of subjects: 39865

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 39865

Group type: EXPERIMENTAL
Intervention: Mindfetalness
Number of subjects: 39865

Group type: COMPARATOR
Intervention: Mindfetalness vs Routine care
Number of subjects: 39865
Study: 35767166

Group type: EXPERIMENTAL
Intervention: GnRH antagonist protocol
Number of subjects: 550
Study: 33314807

Group type: EXPERIMENTAL
Intervention: Reduced protocol (30 shocks/min, 1,200 shocks/session)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Standard protocol (60 shocks/min, 2,400 shocks/session)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Reduced protocol
Number of subjects: 404

Group type: COMPARATOR
Intervention: Standard protocol
Number of subjects: 404
Study: 35217436

Group type: EXPERIMENTAL
Intervention: UROX® Junior
Number of subjects: 0
Study: 33534940

Group type: EXPERIMENTAL
Intervention: Interferon beta-1a (IFNβ-1a) for 40 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 16 weeks followed by Interferon beta-1a (IFNβ-1a) for 24 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon beta-1a (IFNβ-1a) for 40 weeks (originally treated group)
Number of subjects: 0
Study: 32744555

Group type: EXPERIMENTAL
Intervention: Cripp's Pink apple consumption
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phenolic compounds in skin and flesh of apples
Number of subjects: 30
Study: 35861012

Group type: EXPERIMENTAL
Intervention: Be a Mom, a self‐guided web‐based cognitive behavioral therapy intervention
Number of subjects: 367

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 367
Study: 34684639

Group type: EXPERIMENTAL
Intervention: Moderate calorie and protein restriction program (IA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (CA)
Number of subjects: 100
Study: 32700421

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ertugliflozin
Number of subjects: 0
Study: 34702382

Group type: EXPERIMENTAL
Intervention: Septoplasty with radiofrequency ablation (group A)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Septoplasty alone (group B)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Comparison between group A and group B
Number of subjects: 74
Study: 33275085

Group type: EXPERIMENTAL
Intervention: 78 years old + poor physical health
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: 78 years old + normal physical health
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: 48 years old + poor physical health
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: 48 years old + normal physical health
Number of subjects: 147
Study: 33528919

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention plus liraglutide 3.0 mg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Lifestyle intervention alone
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups (after controlling for weight loss)
Number of subjects: 78
Study: 32374724

Group type: EXPERIMENTAL
Intervention: Integrated depression screening and treatment program (Friendship Bench therapy and antidepressants)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control phase (screening-only)
Number of subjects: 0
Study: 36034448

Group type: EXPERIMENTAL
Intervention: YPEG-rhGH 100 μg/kg/week
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: YPEG-rhGH 120 μg/kg/week
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: YPEG-rhGH 140 μg/kg/week
Number of subjects: 43

Group type: COMPARATOR
Intervention: Daily rhGH 35 μg/kg/day
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: YPEG-rhGH (all doses)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: YPEG-rhGH
Number of subjects: 43
Study: 34465327

Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study: 32692805

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (IG)
Number of subjects: 4631

Group type: COMPARATOR
Intervention: Routine care (CG)
Number of subjects: 4631

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (IG) in women with obesity
Number of subjects: 4631

Group type: COMPARATOR
Intervention: Routine care (CG) in women with obesity
Number of subjects: 4631
Study: 35136911

Group type: EXPERIMENTAL
Intervention: cobas plasma separation card (PSC) specimens stored at temperatures from 25ºC to 42ºC for up to 28 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: cobas plasma separation card (PSC) specimens
Number of subjects: 30
Study: 33099855

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block with 30 ml 0.25% bupivacaine at the T8 level
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous infusion of 50 mg of dexketoprofen trometamol (NSAID)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 40
Study: 32145173

Group type: EXPERIMENTAL
Intervention: PRP therapy
Number of subjects: 159

Group type: COMPARATOR
Intervention: Facetoplasty
Number of subjects: 159
Study: 33687145

Group type: EXPERIMENTAL
Intervention: Purple potato extract rich in acylated anthocyanins (152 mg) and hydroxycinnamic acid conjugates (140 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Yellow potato meal with purple potato extract
Number of subjects: 17

Group type: COMPARATOR
Intervention: Yellow potato meal without purple potato extract
Number of subjects: 17
Study: 34108192

Group type: EXPERIMENTAL
Intervention: 1% aqueous chlorhexidine gluconate (CHG)
Number of subjects: 308

Group type: COMPARATOR
Intervention: 2% aqueous chlorhexidine gluconate (CHG)
Number of subjects: 308
Study: 32715985

Group type: EXPERIMENTAL
Intervention: Cremophor RH 40
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unprocessed fexofenadine
Number of subjects: 0
Study: 34966017

Group type: EXPERIMENTAL
Intervention: Ganglion impar block (GIB)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Caudal epidural steroid injection (CESI)
Number of subjects: 68
Study: 33886810

Group type: EXPERIMENTAL
Intervention: Whey protein (WP) supplementation for 12 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 25
Study: 33211829

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted HDL-C levels
Number of subjects: 419649

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted ApoA1 levels
Number of subjects: 419649

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted LDL-C levels
Number of subjects: 419649

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted ApoB levels
Number of subjects: 419649

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted CHOL levels
Number of subjects: 419649

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted non-HDL-C levels
Number of subjects: 419649

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted TG levels
Number of subjects: 419649
Study: 35449070

Group type: EXPERIMENTAL
Intervention: Sirolimus-coated balloon angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncoated balloon angioplasty
Number of subjects: 0
Study: 32808592

Group type: EXPERIMENTAL
Intervention: Inferior tibiofibular mobilization with movement (ITFMWM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo mobilization with movement
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Non-injured ankle
Number of subjects: 75
Study: 34401388

Group type: EXPERIMENTAL
Intervention: Oncokompas (web-based self-management application)
Number of subjects: 655
Study: 616542428

Group type: EXPERIMENTAL
Intervention: Glycerol-enriched yeast culture (GY)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Glycerol (G)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no additive)
Number of subjects: 44
Study: 35142355

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 191
Study: 33863305

Group type: EXPERIMENTAL
Intervention: Sevoflurane-based general anesthesia
Number of subjects: 340

Group type: COMPARATOR
Intervention: Awake-local anesthesia
Number of subjects: 340
Study: 32250135

Group type: EXPERIMENTAL
Intervention: Prosocial spending (spending money on others)
Number of subjects: 5199

Group type: COMPARATOR
Intervention: Personal spending (spending money on oneself)
Number of subjects: 5199
Study: 32204980

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted lumbar puncture (UALP)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard landmark-based lumbar puncture (SLP)
Number of subjects: 166
Study: 34486810

Group type: EXPERIMENTAL
Intervention: Social cognitive skills groups
Number of subjects: 34

Group type: COMPARATOR
Intervention: Facilitated play comparison groups
Number of subjects: 34
Study: 32192496

Group type: EXPERIMENTAL
Intervention: LIG once weekly (QW)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: LIG twice weekly (BW)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Enrofloxacin and silver sulfadiazine twice daily (C)
Number of subjects: 64
Study: 35951253

Group type: EXPERIMENTAL
Intervention: 1-hour training in stimulant diversion prevention
Number of subjects: 76

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 76
Study: 32029903

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX) treatment for at least three months
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX) treatment
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 93
Study: 35012827

Group type: EXPERIMENTAL
Intervention: BTA injections into the subjacent orbicularis oris muscle (4 points group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: BTA injections into the bilateral nasolabial fold region (6 points group)
Number of subjects: 64
Study: 33260274

Group type: EXPERIMENTAL
Intervention: Kindred intervention
Number of subjects: 30
Study: 35085361

Group type: EXPERIMENTAL
Intervention: Cardiac Care Bridge (CCB) program consisting of case management, disease management, and home-based cardiac rehabilitation
Number of subjects: 306

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 306
Study: 33342522

Group type: EXPERIMENTAL
Intervention: Additional $40 in monthly SNAP benefits per child under age 5 years (treatment group)
Number of subjects: 3088

Group type: COMPARATOR
Intervention: Control group (no additional SNAP benefits)
Number of subjects: 3088
Study: 34293933

Group type: EXPERIMENTAL
Intervention: IV esmolol
Number of subjects: 28

Group type: COMPARATOR
Intervention: IV metoprolol
Number of subjects: 28
Study: 32437787

Group type: EXPERIMENTAL
Intervention: Volumetric assessment of ECR using CBCT imaging and Amira software.
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Heithersay classification and treatment decision by independent evaluators.
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Surgical repair decision by independent evaluators.
Number of subjects: 168
Study: 34481388

Group type: EXPERIMENTAL
Intervention: 100 nm PS-NPs
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: 20 µm PS-MPs
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1080
Study: 34888397

Group type: EXPERIMENTAL
Intervention: Visbiome ES
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 35766913

Group type: EXPERIMENTAL
Intervention: MoveStrong program (16 exercise physiologist-led sessions and 2 dietitian-led sessions over 8 weeks)
Number of subjects: 44
Study: 32409219

Group type: EXPERIMENTAL
Intervention: Hypnosis aided awake surgery (HAs)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard awake surgery (SAs)
Number of subjects: 15
Study: 36127422

Group type: EXPERIMENTAL
Intervention: Bifocal + atropine
Number of subjects: 35

Group type: COMPARATOR
Intervention: Atropine only (control)
Number of subjects: 35
Study: 32888861

Group type: EXPERIMENTAL
Intervention: 18G blunt-tipped microcannula
Number of subjects: 68

Group type: COMPARATOR
Intervention: 26G sharp needle
Number of subjects: 68
Study: 33274528

Group type: EXPERIMENTAL
Intervention: Miniscrews (2.0 mm diameter and 10 mm length) placed without pre-drilling and loaded immediately after insertion.
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Miniscrews evaluated after 4 weeks.
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Maximal removal torque evaluated at the end of treatment in Group 3.
Number of subjects: 47
Study: 35192502

Group type: EXPERIMENTAL
Intervention: Transulnar approach (TUA)
Number of subjects: 700
Study: 33373118

Group type: EXPERIMENTAL
Intervention: Self-management program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 36240495

Group type: EXPERIMENTAL
Intervention: Menstrual health education and proper implementation of the Adolescent Reproductive Sexual Health program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Free uninterrupted supply of sanitary pads through school and Anganwadi
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Separate toilets for girls
Number of subjects: 0
Study: 32412273

Group type: EXPERIMENTAL
Intervention: Optical pumping scheme to suppress leakage errors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36007597

Group type: EXPERIMENTAL
Intervention: Nedosiran
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nedosiran (PH1 subgroup)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 33676294

Group type: EXPERIMENTAL
Intervention: Entrectinib
Number of subjects: 71

Group type: COMPARATOR
Intervention: Prior therapy
Number of subjects: 71
Study: 33035459

Group type: EXPERIMENTAL
Intervention: Tazemetostat 800 mg orally twice per day in continuous 28-day cycles
Number of subjects: 62
Study: 37222977

Group type: EXPERIMENTAL
Intervention: Hybrid arch bar (HAB)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Erich arch bar (EAB)
Number of subjects: 44
Study: 34315379

Group type: EXPERIMENTAL
Intervention: Instructions of Daily Care (IDC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 40